A phase II randomised, controlled, assessor-blind, parallel group clinical trial to demonstrate the proof of concept of an experimental pediculicide rinse and Lyclear Creme Rinse in the treatment of head lice - Study of two treatments in the eradication of head lice (25/02/2004)

SSL International plc0 个研究点开始时间: 2005年2月23日最近更新: 2013年7月15日

适应症

试验速览

暂无简介。

•1. Patients aged four and over.
•2. Patients who upon examination, are confirmed to have live head lice.
•3. Patients who give written informed consent, or if the patient is under 16 years of age whose parent/guardian gives written informed consent to participate in the study.
•4. Patients who will be available for home visits from IRD study team members over the next 14 days.
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•1. Patients with a known sensitivity to any of the ingredients in Product X or Lyclear (e.g. pyrethroids or chrysanthemums).
•2. Patients with a secondary bacterial infection of the scalp (e.g. impetigo) or who have a long term scalp condition (e.g. psoriasis of the scalp).
•3. Patients who have been treated with other head lice products within the last two weeks.
•4. Patients who have bleached hair, or hair that has been colour treated or permanently waved within the last four weeks (wash in/wash out colours are acceptable).
•5. Patients who have been treated with the antibiotics Co-Trimoxazole, Septrin or Trimethoprim within the last four weeks, or who are currently taking such a course.
•6. Pregnant or nursing mothers.
•7. Patients who have participated in another clinical study within 1 month before entry to this study.
•8. Patients who have already participated in this clinical study.

发起方

SSL International plc